National Institutes of Health (press release)New approach to immunotherapy leads to complete response in …National Institutes of Health (press release)A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) h… Continue reading
Medical XpressNew approach to immunotherapy leads to complete response in breast cancer patientMedical XpressA novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast … Continue reading
Medical XpressNew approach to immunotherapy leads to complete response in breast cancer patientMedical XpressA novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast … Continue reading
TAPinto.netImmunotherapy Clinical Trial at Overlook Medical Center Reveals Brain Tumor Shrinkage, Continues with Phase 3 StudyTAPinto.netSUMMIT, NJ — Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with… Continue reading
NPR |
Therapy Made From Patient’s Immune System Shows Promise For Advanced Breast Cancer
NPR Doctors at the National Institutes of Health say they’ve apparently completely eradicated cancer from a patient who had untreatable, advanced breast cancer. The case is raising hopes about a new way to harness the immune system to fight some of the … New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast CancerForbes Experimental immune treatment saves dying breast cancer patientNBCNews.com Immune-System Therapy Eradicated Breast Cancer in New BreakthroughBloomberg Los Angeles Times –The Independent –La Crosse Tribune all 538 news articles » |
Endpoints News |
Sarepta snags its partner’s CSO, Louise Rodino-Klapac, to lead new gene therapy unit
Endpoints News Putting one more arrow in its muscular dystrophy quiver, Sarepta has snagged a top executive from one of its partners to lead the company’s newly-created gene therapy unit. Louise Rodino-Klapac is coming on board as vice president of gene therapy. |